ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised.
Brand(s)
Last updated
Summary
Product
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
Issue
Health products - Product quality
What to do
What to do:
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|
| ERYTHROMYCIN OPHTHALMIC OINTMENT USP | DIN 02326663 | Ointment | Erythromycin 5 mg/g | 2024L02 |
Issue
The sterility of the product could be compromised in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Steri-Med Pharma inc.
242, Rue Saint-Cyrille
Upton, QC
J0H 2E0
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Recall date
Identification number
RA-82101
Get notified
Receive emails about new and updated recall and safety alerts.